Agitation in Alzheimer Disease: What Clinicians Need to Ask, Assess, and Address
A geriatric psychiatrist's clinical pearls on agitation in AD, incluiding behavioral cues, triggers, and evidence-based treatment strategies for primary care.
Pearls for Primary Care: How to Talk About Agitation in Alzheimer Disease with Caregivers
A geriatric psychiatrist talks about the importance of asking caregivers about behavior in order to understand and treat agitation in Alzheimer dementia.
George Grossberg, MD, on Helping Families Face Alzheimer Agitation in a Loved One
Agitation, one of the most common symptoms AD, affects up to 70% of adults with the condition, and is one of the most challenging for caregivers to deal with.
Expert Perspectives 2024: Treatment for Agitation in Alzheimer Disease with George Grossberg, MD
Agitation affects at least one half of adults with Alzheimer disease; geriatric psychiatrist Grossberg explains the symptoms and new treatments in this year's video series.
For Alzheimer Agitation, a Novel, Oral NMDA Inhibitor Could be the Next Targeted Treatment
Geriatric psychiatrist and neurocognitive researcher George Grossberg, MD, highlights the mechanism of action for the new dextromethorphan/bupropion combination.
